UBS Assumes Inspire Medical Systems at Sell, Lowers Price Target of $39
Inspire Medical Systems Inc INSP
$50.21
▲ +0.38%
(+$0.19)
📅 Earnings This Week
Open
$49.92
Prev Close
$50.02
Day Range
$49.02 – $50.39
52W Range
$38.91 – $147.03
Market Cap
$1.45B
P/E (TTM)
11.03
Beta
0.66
EPS (TTM)
$4.48
📋 Company Profile
| Industry | Health Care |
| Country | US |
| Exchange | NEW YORK STOCK EXCHANGE, INC. |
| Currency | USD |
| IPO Date | 2018-05-03 |
| Shares Out. | 28,810,000 |
| Website | inspiresleep.com/ ↗ |
| Phone | 13026587581 |
| Employees | 1,333 |
| Revenue | $204.6M |
| Gross Profit | $176.9M |
| Net Income | -$11.3M |
| Free Cash Flow | $96.7M |
| Total Assets | $911.4M |
| Total Liabilities | $119.0M |
| Equity | $792.3M |
About Inspire Medical Systems Inc
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and All other countries wherein, it generates a majority of its revenue from the United States. Its segment revenues are derived from the sales of its product, the Inspire system, to hospitals and ambulatory surgery centers in the U.S. and in selected countries in Europe and the Asia Pacific region.
Inspire Medical Systems Inc is a publicly traded company under the ticker symbol INSP on the NEW YORK STOCK EXCHANGE, INC., operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
25 analysts (2026-07-01)